Myrobalan Therapeutics

We are thrilled to welcome Grant Bogle to the Board of Directors at Myrobalan Therapeutics!   Grant brings a wealth of experience, having served as CEO of Epizyme, Inc. from 2021-2022 and as a Board Member from 2019-2022 until its acquisition by Ipsen in 2022. Prior to that, he was the SVP and COO of TESARO, which was acquired by GSK for $5.1B in 2018. He has also held senior executive roles at several other renowned pharmaceutical and biotech companies, including Millennium, ViaCord, Roche, Knoll, and McKesson Specialty Health/U.S. Oncology.   This announcement comes just a month after Myrobalan Therapeutics raised an additional $9 million from three new investors in a subsequent closing of its Series A round, bringing total Series A funding to $33 million.   We are incredibly excited to have Grant join us as we continue our journey as a leading CNS biotech company. Welcome to the Board, Grant! See the full press release here: https://lnkd.in/e-P56Gqd https://lnkd.in/epiw4ESZ

Yesterday, the Myrobalan Therapeutics Medford team traded our laptops for life vests, paddles, and kayaks. We had an amazing time heading down the Mystic River, where we saw turtles, herons, and other local wildlife. We hope they weren't too disturbed by our kayak dodgeball game…😆   Here’s to many more adventures together and to the wonderful team that makes Myrobalan a great place to work!

Congratulation and Welcome to our Q2 New Hires! We are thrilled to have you join the team and know you will make an impact addressing the unmet need posed by neurodegenerative and demyelinating disorders.    Richard Gallegos, Associate Director, DMPK Bowie T., Sr. Accountant  Simon Mazza-Lunn, Associate Director, Program Management 

We are thrilled to announce that Myrobalan Therapeutics Co-Founder, Professor Guoping Feng of Massachusetts Institute of Technology and the Broad Institute of MIT and Harvard, has been inducted into the National Academy of Sciences (NAS)! This prestigious honor recognizes Professor Feng's exceptional contributions to the field of neuroscience. His research has also been foundational to the inception of our own company. Professor Feng is also a member of the National Academy of Medicine (NAM), further highlighting his profound impact on the scientific and medical community. Join us in congratulating Professor Feng on this well-deserved recognition!

ICYMI - Brad Loncar from BiotechTV interviewed Myro at MassBio's #AlignSummit2024. See the quick take from our CEO, Dr. Jing Wang.

We will be attending MassBio 2024 Align Summit w/ insights by McKinsey & Company & Locust Walk. Come see our company presentation at 2:40PM ET this Thursday, April 25th. Register here: https://lnkd.in/euynZvkA #AlignSummit24

Exciting new opportunity on our Program Management team! #programmanagement #hiring

Come meet us at MassBio’s Align Summit on April 25th!

Celebrating the Remarkable Women Driving Innovation at Myrobalan on International Women's Day! As we commemorate International Women's Day, we take pride in acknowledging the diversity and excellence within our team of talented women at Myrobalan. A bit of history: Myrobalan was co-founded by our visionary CEO, Dr. Jing Wang. With 18+ years of industry experience after earning her Ph.D. in neuroscience at Harvard, she ignited our mission to innovate for the betterment of patients battling ALS, MS, and AD, along with other degenerative and demyelinating diseases. Let's not forget to shine a spotlight on our exceptional team. A picture says a thousand words. These remarkable women, with extensive backgrounds in biotech, have achieved monumental milestones—from groundbreaking research to bringing life-changing treatments to patients. Their dedication and perseverance exemplify the spirit of innovation, propelling us forward every day. Let's celebrate their outstanding accomplishments and recommit to creating equal opportunities for all women in science and technology. #InternationalWomensDay #WomenInSTEM #Innovation #DiversityAndInclusion #MyrobalanImpact

We're #hiring a new Associate Director, Drug Metabolism and Pharmacokinetics (DMPK) in Medford, Massachusetts. Apply today or share this post with your network.